GUIDED THERAPEUTICS INC (GTHP) › Cash & EquivalentsGUIDED THERAPEUTICS INC (GTHP) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: $230.0K2010-12-31: $3.27M2011-12-31: $2.20M2012-12-31: $1.04M2013-12-31: $613.0K2014-12-31: $162.0K2015-12-31: $35.0K2016-12-31: $14.0K2017-12-31: $1.0K2018-12-31: $02019-12-31: $899.0K2020-12-31: $182.0K2021-12-31: $643.0K2022-12-31: $2.31M$2.31M2009-12-31Cash & Equivalents (USD)2022-12-31Period endedCash & EquivalentsChange YoYSource filing2022-12-31$2.31M+259.7%2023-03-30Balance as of period end2021-12-31$643.0K+253.3%2023-03-30Balance as of period end2020-12-31$182.0K-79.8%2022-03-30Balance as of period end2019-12-31$899.0K—2021-04-07Balance as of period end2018-12-31$0-100.0%2020-04-20Balance as of period end2017-12-31$1.0K-92.9%2020-04-20Balance as of period end2016-12-31$14.0K-60.0%2019-05-08Balance as of period end2015-12-31$35.0K-78.4%2018-04-20Balance as of period end2014-12-31$162.0K-73.6%2017-03-22Balance as of period end2013-12-31$613.0K-41.3%2016-03-15Balance as of period end2012-12-31$1.04M-52.5%2015-03-25Balance as of period end2011-12-31$2.20M-32.7%2014-03-26Balance as of period end2010-12-31$3.27M+1320.9%2013-03-27Balance as of period end2009-12-31$230.0K—2012-03-28Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)